Hamel Associates, Inc. Pfizer Inc Transaction History

Hamel Associates, Inc.

$324 Million
Q3 2024

A detailed history of Hamel Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Hamel Associates, Inc. holds 130,018 shares of PFE stock, worth $3.44 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

130,018

Previous 125,608 3.51%

Holding current value

$3.44 Million

Previous $3.51 Million 7.06%

% of portfolio

1.16%

Previous 1.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$27.7 - $31.39 $122,157 - $138,429	4,410 Added 3.51%	130,018 $3.76 Million
Q2 2024 Aug 02, 2024	BUY	$25.26 - $29.6 $492,266 - $576,844	19,488 Added 18.36%	125,608 $3.51 Million
Q1 2024 Apr 23, 2024	BUY	$25.89 - $29.73 $2.75 Million - $3.15 Million	106,120 New	106,120 $2.94 Million
Q2 2021 Aug 04, 2021	SELL	$35.91 - $40.68 $485,682 - $550,197	-13,525 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $929,347 - $1.05 Million	-27,750 Reduced 67.23%	13,525 $490,000
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $23,094 - $29,366	-690 Reduced 1.64%	41,275 $1.52 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $160,337 - $188,112	-5,050 Reduced 10.74%	41,965 $1.54 Million
Q1 2020 May 07, 2020	BUY	$27.03 - $38.62 $364,229 - $520,404	13,475 Added 40.18%	47,015 $1.54 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $53,495 - $60,710	1,625 Added 5.09%	33,540 $1.31 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $268,692 - $348,415	8,270 Added 34.98%	31,915 $1.15 Million
Q2 2019 Aug 05, 2019	SELL	$36.98 - $41.52 $27,734 - $31,140	-750 Reduced 3.07%	23,645 $1.02 Million
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $131,250 - $144,200	-3,500 Reduced 12.55%	24,395 $1.04 Million
Q1 2018 May 03, 2018	SELL	$31.91 - $37.02 $260,066 - $301,713	-8,150 Reduced 22.61%	27,895 $990,000
Q2 2017 Aug 11, 2017	BUY	N/A	36,045	36,045 $1.21 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hamel Associates, Inc. with notifications on news.

Account

Hamel Associates, Inc. Pfizer Inc Transaction History